Mirtazapine may reduce nocturnal pruritus in patients with inflammatory skin disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1452, 2004-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus for the treatment of inflammatory skin disease

By Wolff Klaus Stuetz Anton

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 643-655

Informa Healthcare

Access to resources Recommend Favorite

NSAIDs may reduce the risk of Alzheimer's disease

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Atorvastatin May Correct Dyslipidemia in Adult Patients at Risk for Alzheimer’s Disease Through an Anti-Inflammatory Pathway

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 80-85

Bentham Science Publishers

Access to resources Recommend Favorite

CMLVAX100 vaccine may reduce residual disease in CML

Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Leflunomide may reduce viral load in patients with polyomavirus type BK nephropathy

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite